Background The knowledge on bovine vaccines against respiratory viruses on bronchoalveolar fluid cells is scarce. Objective To compare the effects of a commercial intranasal (IN) and intramuscular (IM) vaccine against bovine respiratory disease (BRD) complex viruses on bronchoalveolar fluid cells of healthy heifers. Methods 21 healthy heifers were assigned to three treatment groups: control (CO, N = 7), intranasally vaccinated (IN) (n = 7), and intramuscularly vaccinated (IM) (n = 7). The IN group received 1 mL of the commercial vaccine in each nostril once containing attenuated BoHV-1, bPIV-3, and BRSV. The IM group was vaccinated with two doses of 2 mL with an interval of 21 days of the commercial vaccine containing attenuated BoHV-1, bPIV-3, and BRSV plus inactivated BVDV. At day 0 (D0), before the first vaccine dose, and at D3, D7, and D21, after the last vaccine dose, airway bronchoscopy was performed to observe local irritation and collect bronchoalveolar lavage fluid (BALF). The bronchoalveolar count, cytological evaluation, bronchoalveolar cell oxidative metabolism, and total bronchoalveolar IgA and IgG were measured. Results The IN vaccine increased neutrophil cellularity at D7 and D21 and total IgA at D3 in BALF. Total IgA in BALF also increased at D3 and oxidative metabolism of bronchoalveolar cells at D21 lowered compared to the CO group. Following IM vaccination there was no alteration of immunoglobulins or cell oxidative metabolism in BALF. Both vaccines reduced the number of alveolar macrophages. Conclusion Both vaccines induced bronchoalveolar inflammation during the establishment of the vaccine immunity, which was more expressive in the IN protocol.
O uso de probióticos a base de leveduras melhora o ganho de peso e o sistema imunológico de bovinos frente a grandes desafios imunológicos, no entanto permanece a dúvida se seu uso também apresentaria efeito em desafios mais tênues. Desta maneira, o presente trabalho verificou se o uso de probiótico a base de Enterococcus faecium e Saccaromyces cerevisiae via oral interfere na imunidade inata e no peso de bezerros sadios, em fase de crescimento, alimentados principalmente com silagem de milho. Para tanto, 12 bezerros da raça Jersey (120 kg ±50 kg e 4-7 meses de idade), foram alocados nos grupos controle (n=6) ou tratamento (n=6), de acordo com a oferta de probiótico (2g/dia, via oral) durante 45 dias. Nos dias 0, 15, 30 e 45, os animais foram submetidos a pesagens, exames clínicos, e colheita de sangue para realização de hemograma e mensuração do metabolismo oxidativo neutrofílico. Observou-se que, o probiótico promoveu pequeno e pontual incremento na função neutrofilica sanguínea (P=0,10, D15), incremento nos valores de hematócrito e hemoglobina (P=0,03 e 0,05, D45), além de maior ganho de peso nas fases iniciais da administração do suplemento (P=0,05), permitindo concluir que o suplemento é benéfico para animais em fase de adaptação de trocas de dieta e de manejo, mesmo quando estes desafios são tênues.
Mycotoxins often contaminate cattle food, which can cause liver damage, immunosuppression, and reduced milk production. Although previous studies have shown the benefits of adsorbents in farm animals, knowledge regarding their mechanism of action is limited, especially when intoxication occurs due to naturally contaminated diets. The present study aimed to assess whether the daily oral administration of mycotoxin adsorbent bentonite clay based on aluminosilicate for 56 days, would attenuate these changes in 18 dairy cows, which were multiparous in the middle of the lactation stage, and were consuming a diet containing fumonisin B1 and B2, zearalenone, and desoxynivalenol. The animals were divided into treatment (TG, n = 9) and control (CG, n = 9) groups, and subjected to assessment of liver functions, hematological assessments, assessment of oxidative leucocyte metabolism by the tetrazolium nitroazul (NBT) technique, and physical chemical analysis of milk, every week for two months, totaling eight analyses. It was observed that the use of the adsorbent caused a reduction in the milk excretion of aflatoxin M1 (AFM1), an increase in levels of serum protein (p = 0.03) and albumin (p = 0.0001), an increase in leukocyte oxidative metabolism from day 24 of treatment(p = 0.05), and increased milk production from the day 16 of treatment (p = 0.08). There was no improvement in the physicochemical indices of the milk. It was concluded that the use of an aluminosilicate-based adsorbent was able to attenuate the effects of mycotoxins on the function of leukocytes and increase milk production.
As mycotoxins are consistent contaminants in the dairy cow diet, the use of adsorbents is recommended, although there are no ideal adsorbents. Although there are studies on this subject, few have focused on chronic natural intoxications. Here, we evaluated the effect of bentonite adsorbents associated with liver antioxidants on the health and milk production of dairy cows fed a diet containing naturally-produced fumonisin, zearalenone, and deoxynivalenol. Eighteen dairy cows (bodyweight 550 ±50 kg, 5 ± 2 years old, and 30 ± 1,25 kg/day milk production) in the middle of lactation were divided into groups: treatment (TG, n = 9, 22 g/day of supplement added to diet) and control (CG, n = 9, without supplement). A physical examination was performed, weekly over 56 days and blood was collected for liver and immune assessments. Milk was harvested to evaluate milk production and content (fat protein, somatic cell count, and lactose). The additive promoted beneficial effects on the liver from the 24th day due to a decrease in the enzymatic activities of gamma-glutamyltransferase and lactate dehydrogenase and increased serum protein and albumin levels. There were improvements in health, evidenced as fewer clinical manifestations of the disease, greater leukocyte oxidative metabolism capacity, and a lower neutrophil lymphocytes ratio. The treatment also promoted a 19% increase in milk volume. It was concluded that the additive promoted health benefits and milk production in dairy cows.
Treatment of the bovine respiratory disease complex (BRDC) can elicit high bacterial resistance and stress to steers in a feedlot. Therefore, the present study aimed to evaluate three therapeutic protocols with long-acting antibiotics against BRDC naturally acquired in steers finished in feedlot. In a total of 80 animals finished in a feedlot, 18 steers showed clinical signs compatible with BRDC (mucopurulent nasal secretion, lung auscultation alteration, leukocytosis, and decrease of dry matter intake). These animals were randomly treated: marbofloxacin in a single dose (M1), marbofloxacin in two doses (M2), or ceftiofur in a single dose (C1) on Day 0. The clinical score of pneumonia, hemogram, daily food intake, and body weight were analyzed during 7 days. On slaughter day (Day 100), the body weight and frequency of lungs with pneumonia was evaluated. On Day 7, M2 showed absence of pneumonia, and M1 and C1 still showed a clinical score of mild pneumonia (P = 0.01). On day 2 and day 3 M2 showed a higher dry matter intake than others treatments (P = 0.05). C1 showed a lower body weight than others group on day 1 and 2 (P = 0.05). The C1 and M1 showed a higher pneumonia frequency than M2 (P = 0.02). The M2 slaughter weight was numerically higher than the other treatments. We conclude the marbofloxacin in two doses eliminated the pneumonia ́s clinical symptoms and allowed the animals to return the productivity earlier than other protocols.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.